Tenax Therapeutics (TENX) Competitors $6.11 -0.06 (-0.97%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$6.00 -0.11 (-1.80%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TENX vs. ZURA, SAVA, HLVX, COYA, CHRS, MGNX, CLYM, PLRX, ANIX, and ONCYShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include Zura Bio (ZURA), Cassava Sciences (SAVA), HilleVax (HLVX), Coya Therapeutics (COYA), Coherus Oncology (CHRS), MacroGenics (MGNX), Climb Bio (CLYM), Pliant Therapeutics (PLRX), Anixa Biosciences (ANIX), and Oncolytics Biotech (ONCY). These companies are all part of the "pharmaceutical products" industry. Tenax Therapeutics vs. Its Competitors Zura Bio Cassava Sciences HilleVax Coya Therapeutics Coherus Oncology MacroGenics Climb Bio Pliant Therapeutics Anixa Biosciences Oncolytics Biotech Zura Bio (NASDAQ:ZURA) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Do analysts rate ZURA or TENX? Zura Bio presently has a consensus target price of $14.33, suggesting a potential upside of 842.98%. Tenax Therapeutics has a consensus target price of $17.50, suggesting a potential upside of 186.42%. Given Zura Bio's higher possible upside, analysts clearly believe Zura Bio is more favorable than Tenax Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zura Bio 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Tenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Does the media favor ZURA or TENX? In the previous week, Zura Bio had 3 more articles in the media than Tenax Therapeutics. MarketBeat recorded 3 mentions for Zura Bio and 0 mentions for Tenax Therapeutics. Zura Bio's average media sentiment score of 0.76 beat Tenax Therapeutics' score of 0.00 indicating that Zura Bio is being referred to more favorably in the media. Company Overall Sentiment Zura Bio Positive Tenax Therapeutics Neutral Which has better valuation & earnings, ZURA or TENX? Tenax Therapeutics is trading at a lower price-to-earnings ratio than Zura Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZura BioN/AN/A-$45.39M-$0.70-2.17Tenax TherapeuticsN/AN/A-$17.60M-$2.48-2.46 Is ZURA or TENX more profitable? Tenax Therapeutics' return on equity of -31.51% beat Zura Bio's return on equity.Company Net Margins Return on Equity Return on Assets Zura BioN/A -42.84% -35.22% Tenax Therapeutics N/A -31.51%-30.35% Which has more volatility and risk, ZURA or TENX? Zura Bio has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Do institutionals & insiders believe in ZURA or TENX? 61.1% of Zura Bio shares are held by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are held by institutional investors. 14.2% of Zura Bio shares are held by company insiders. Comparatively, 3.1% of Tenax Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryZura Bio beats Tenax Therapeutics on 8 of the 13 factors compared between the two stocks. Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.60M$3.01B$5.56B$9.47BDividend YieldN/A2.41%4.31%4.17%P/E Ratio-2.4616.5729.3723.99Price / SalesN/A313.98444.7496.71Price / CashN/A42.1735.8458.51Price / Book0.237.818.085.58Net Income-$17.60M-$54.52M$3.26B$265.35M7 Day Performance-2.08%0.41%0.44%-0.07%1 Month Performance6.26%9.93%4.82%1.76%1 Year Performance50.12%15.18%30.27%25.39% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics1.3201 of 5 stars$6.11-1.0%$17.50+186.4%+62.5%$25.60MN/A-2.469Upcoming EarningsZURAZura Bio3.7209 of 5 stars$1.46-2.7%$14.33+881.7%-59.9%$102.56MN/A-2.093News CoveragePositive NewsUpcoming EarningsSAVACassava Sciences3.6216 of 5 stars$2.29+8.0%$54.50+2,279.9%-92.3%$102.41MN/A-1.5330News CoverageUpcoming EarningsHLVXHilleVax1.7546 of 5 stars$2.07+1.5%$2.00-3.4%+29.7%$102.29MN/A-0.9620News CoverageEarnings ReportUpcoming EarningsHigh Trading VolumeCOYACoya Therapeutics1.944 of 5 stars$6.34+4.1%$16.50+160.3%+4.2%$101.86M$3.69M-5.936Upcoming EarningsCHRSCoherus Oncology3.9098 of 5 stars$0.87-1.1%$4.68+439.6%-31.2%$101.77M$266.96M-0.77330News CoverageGap UpMGNXMacroGenics4.2499 of 5 stars$1.64+3.8%$5.33+225.2%-55.8%$99.68M$152.43M-1.84430CLYMClimb Bio2.714 of 5 stars$1.70+17.2%$9.00+429.4%N/A$97.99MN/A-0.719News CoveragePositive NewsUpcoming EarningsHigh Trading VolumePLRXPliant Therapeutics4.007 of 5 stars$1.70+7.6%$13.31+683.1%-87.1%$96.99M$1.58M-0.4790News CoverageANIXAnixa Biosciences3.6902 of 5 stars$3.26+8.3%$9.00+176.1%-3.1%$96.96M$210K-8.585Analyst ForecastONCYOncolytics Biotech2.1518 of 5 stars$0.88-10.8%$4.33+390.7%-7.9%$96.43MN/A-3.0530Gap Down Related Companies and Tools Related Companies Zura Bio Alternatives Cassava Sciences Alternatives HilleVax Alternatives Coya Therapeutics Alternatives Coherus Oncology Alternatives MacroGenics Alternatives Climb Bio Alternatives Pliant Therapeutics Alternatives Anixa Biosciences Alternatives Oncolytics Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TENX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENX Stock Alerts